Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study-Reference-Cited by-同舟云学术

Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study

Published:2021-09 Issue: Volume:122 Page:108128
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Casciato Sara,Quarato Pier Paolo,Gialluisi Alessandro^ORCID,D'Aniello Alfredo,Mascia Addolorata,Grammaldo Liliana G.,Di Gennaro Giancarlo

Funder

Fondazione Umberto Veronesi

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference30 articles.

1. Epilepsy after the first drug fails: substitution or add-on?;Kwan;Seizure,2000

2. St Louis EK, Rosenfeld WE, Bramley T. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol 2009;7:77‐82.

3. Tomson T, Battino D, Bonizzoni E, et al. Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP. Neurology. 2015;85:580‐588.

4. Response to treatment schedules after the first antiepileptic drug failed;Chi;Epilepsia,2018

5. European Medicines Agency. Vimpat (Lacosamide). EMA Summary of Product Characteristics. Brussels, BE: UCB Pharma SA; 2017. UCB Pharma Inc. Vimpat (Lacosamide) US Prescribing Information. Smyrna, GA: UCB Pharma Inc; 2017.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide;Epilepsy & Behavior;2023-08

2. Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system;Seizure: European Journal of Epilepsy;2023-08

3. Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study;BMC Pediatrics;2023-05-20

4. Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience;Pediatric Neurology;2023-05

5. Therapeutic Drug Monitoring of Lacosamide in Chinese Pediatric Patients with Epilepsy: Efficacy and Factors Influencing the Plasma Concentration;European Journal of Drug Metabolism and Pharmacokinetics;2022-11-23